Banque Cantonale Vaudoise’s VanEck Biotech ETF BBH Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$288K	Hold	1,532	–	–	0.01%	581
2025 Q4	$290K	Hold	1,532	–	–	0.01%	530
2025 Q3	$254K	Buy	1,532 +326	+27%	+$53.2K	0.01%	535
2025 Q2	$185K	Buy	+1,206	New	+$180K	0.01%	552
2024 Q3	$55K	Hold	310	–	–	﹤0.01%	620
2024 Q2	$52K	Hold	310	–	–	﹤0.01%	788
2024 Q1	$52K	Hold	310	–	–	﹤0.01%	777
2023 Q4	$51K	Sell	310 -20	-6%	-$3.08K	﹤0.01%	798
2023 Q3	$51K	Hold	330	–	–	﹤0.01%	967
2023 Q2	$51K	Sell	330 -23	-7%	-$3.67K	﹤0.01%	961
2023 Q1	$57K	Buy	353 +15	+4%	+$2.43K	﹤0.01%	936
2022 Q4	$54K	Buy	+338	New	+$53.5K	﹤0.01%	945
2020 Q3	–	Sell	-840	Closed	-$137K	–	1054
2020 Q2	$137K	Buy	+840	New	+$128K	0.01%	733

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Banque Cantonale Vaudoise's BBH Position: Q1 2026 in Review

Banque Cantonale Vaudoise held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 1,532 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #581.

Banque Cantonale Vaudoise first reported a position in BBH in Q2 2020 and has held it in 13 quarters since. The position peaked at $290K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Banque Cantonale Vaudoise held 1,532 shares of VanEck Biotech ETF worth $288K as of Q1 2026.
Banque Cantonale Vaudoise left its VanEck Biotech ETF share count unchanged in Q1 2026.
VanEck Biotech ETF made up 0.01% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #581 holding.
Banque Cantonale Vaudoise first reported a position in VanEck Biotech ETF in Q2 2020 and has held it in 13 quarters since.
Banque Cantonale Vaudoise's VanEck Biotech ETF position peaked at $290K in Q4 2025.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.